leadf
logo-loader
viewBioSig Technologies, Inc.

BioSig forms R&D program with Mayo Clinic to develop AI and machine learning for its PURE EP System

BioSig Technologies, Inc. (NASDAQ: BSGM) Executive Vice President Natasha Drapeau tells Proactive the Westport, Connecticut-based medical technology company has formed its fifth R&D program collaboration with the Mayo Foundation for Medical Education and Research. Drapeau explains how the program will aim to develop Artificial Intelligence and machine learning-powered software for its PURE EP system.

Quick facts: BioSig Technologies, Inc.

Price: 4.46 USD

NASDAQ:BSGM
Market: NASDAQ
Market Cap: $137.01 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioSig Technologies, Inc. named herein, including the promotion by the Company of BioSig Technologies, Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

BioSig Technologies taps seasoned life sciences exec Brenda Castrodad to...

BioSig Technologies, Inc. (NASDAQ:BSGM) Head of Human Resources Brenda Castrodad tells Proactive she's excited to begin work at the Westport, Connecticut-based medical technology company. Castrodad tells Proactive about her experience in leading organizational development in start-ups and...

1 week, 1 day ago

2 min read